|Mr. Murray S. Kessler||CEO, Pres & Director||3.06M||N/A||1960|
|Mr. Raymond P. Silcock||CFO, Principal Accounting Officer & Exec. VP||1.48M||N/A||1951|
|Mr. James E. Dillard III||Exec. VP & Chief Scientific Officer||1.01M||N/A||1964|
|Mr. Svend Andersen||Exec. VP & Pres of Consumer Healthcare International||1.08M||N/A||1962|
|Mr. Ronald C. Janish||Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain||N/A||N/A||1966|
|Mr. Shannon Hukill||Sr. Director of Technical Operations||N/A||N/A||N/A|
|Mr. Thomas M. Farrington||Chief Information Officer & Exec. VP||N/A||N/A||1957|
|Mr. Bradley Joseph||VP of Global Investor Relations & Corp. Communications||N/A||N/A||N/A|
|Mr. Todd W. Kingma||Exec. VP, Gen. Counsel & Sec.||N/A||N/A||1960|
|Ms. Mary Reilly-Brest||Director of Global Organizational and Human Resource Devel.||N/A||N/A||N/A|
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid, 24HR, Good Sense, Zephrex D, ScarAway, Plackers, and Rembrandt. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands and consumer focused products through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Perrigo Company plc’s ISS Governance QualityScore as of October 31, 2019 is 4. The pillar scores are Audit: 3; Board: 6; Shareholder Rights: 4; Compensation: 3.